<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6968865\results\search\country\results.xml">
  <result pre="Acids : People and Places : Geographical Locations : Oceania:" exact="Vanuatu" post="Validation of the easyscreen flavivirus dengue alphavirus detection kit"/>
  <result pre="on 3base amplification technology and its application to the 2016/17" exact="Vanuatu" post="dengue outbreak 3base technology and its application to dengue"/>
  <result pre="validation the pan-viral assays were then tested during the 2016–2017" exact="Vanuatu" post="dengue-2 outbreak. Positive results were detected in 116 positives"/>
  <result pre="worldwide. Year Location Virus Cases Death rate complications Reference 2011" exact="Uganda" post="YFV 181 45 (24.9%) [11] 2012 Texas, USA WNV"/>
  <result pre="[11] 2012 Texas, USA WNV 1,868 89 (5%) [12] 2015" exact="India" post="DENV 99,913 200 (0.2%) [13] 2016–2017 Latin America Caribean"/>
  <result pre="(0.8%) [15] 2016 Odisha JEV 336 103 (30.6%) [16] 2017" exact="Bangladesh" post="CHIKV 13,176 N/A [17] 2017 Australia RRV &amp;gt;1,000 N/A"/>
  <result pre="103 (30.6%) [16] 2017 Bangladesh CHIKV 13,176 N/A [17] 2017" exact="Australia" post="RRV &amp;gt;1,000 N/A [18] The global distribution and severity"/>
  <result pre="successfully applied these assays to screen samples in the 2016/17" exact="Vanuatu" post="dengue outbreak. Methods Ethics statement The interim ethics committee"/>
  <result pre="DENV infection were collected at Port Vila Central Hospital, Efate," exact="Vanuatu" post="between December 2016 to March 2017. 100 μL of"/>
  <result pre="of 187 samples were tested (Table 5) during the 2016–2017" exact="Vanuatu" post="dengue-2 outbreak. The original testing algorithm consisted of screening"/>
  <result pre="emerged. 10.1371/journal.pone.0227550.t005Table 5 Results of clinical sample obtained during the" exact="Vanuatu" post="outbreak. Number of sample % Positive pan-flavivirus 116 62"/>
  <result pre="TBEV endemic in Eurasia, JEV in Southeast Asia, MVEV in" exact="Australia" post="and Papua New Guinea, and SLEV mainly found in"/>
  <result pre="in Eurasia, JEV in Southeast Asia, MVEV in Australia and" exact="Papua New Guinea," post="and SLEV mainly found in the United States and"/>
  <result pre="and Papua New Guinea, and SLEV mainly found in the" exact="United States" post="and more rarely in Canada and Mexico. Similar geographical"/>
  <result pre="mainly found in the United States and more rarely in" exact="Canada" post="and Mexico. Similar geographical patterns are also seen with"/>
  <result pre="with critical response measures to limit the spread of disease." exact="Vanuatu" post="is a Pacific Island nation located in the South"/>
  <result pre="the presence of DENV samples had to be sent to" exact="New Zealand" post="in order to type the strain responsible by molecular"/>
  <result pre="required thus removing the lengthy process of sending samples to" exact="New Zealand" post="for typing. From the 12th to 24th March 2017"/>
  <result pre="dengue cases mirrors the age demographics of the islands of" exact="Vanuatu" post="[35]. Fig 7 shows the number of DENV dengue"/>
  <result pre="per 1000 residents included. Efate has the largest population of" exact="Vanuatu" post="with 86,250 residents and as would be expected also"/>
  <result pre="with a total of 116 confirmed cases from the whole" exact="Vanuatu" post="region, perhaps the islands Emae, Tongoa and Ambae had"/>
  <result pre="1000. The figure shows the population of each island in" exact="Vanuatu" post="with the number of cases per 1000 island population"/>
 </snippets>
</snippetsTree>
